| Risk of hospitalization and death associated with pimavanserin use in older adults with Parkinson disease YJ Hwang, GC Alexander, H An, TJ Moore, HB Mehta Neurology 97 (13), e1266-e1275, 2021 | 37 | 2021 |
| Use of hydroxychloroquine, remdesivir, and dexamethasone among adults hospitalized with COVID-19 in the United States: a retrospective cohort study HB Mehta, H An, KM Andersen, O Mansour, V Madhira, ES Rashidi, ... Annals of internal medicine 174 (10), 1395-1403, 2021 | 31 | 2021 |
| Development and validation of the summary elixhauser comorbidity score for use with ICD-10-CM–Coded data among older adults HB Mehta, S Li, H An, JS Goodwin, GC Alexander, JB Segal Annals of internal medicine 175 (10), 1423-1430, 2022 | 12 | 2022 |
| Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010–2016 S Ardeshirrouhanifard, H An, RK Goyal, MA Raji, JB Segal, GC Alexander, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 42 (5 …, 2022 | 9 | 2022 |
| Comparative effectiveness and safety of direct oral anticoagulants versus warfarin among adults with cancer and atrial fibrillation HB Mehta, H An, S Ardeshirrouhanifard, MA Raji, GC Alexander, JB Segal Circulation: Cardiovascular Quality and Outcomes 15 (12), e008951, 2022 | 5 | 2022 |
| Comparative effectiveness of abiraterone and enzalutamide in the first-line treatment of metastatic castration-resistant prostate cancer (mCRPC): A retrospective cohort study … H An, MW Schoen, J Rider, AE Schorer, J Ken, L Chen, A Alabaster, ... Journal of Clinical Oncology 41 (6_suppl), 175-175, 2023 | 1 | 2023 |
| Comparative effectiveness of direct oral anticoagulants versus warfarin among nursing home residents with atrial fibrillation H Mehta, H An, J Segal, J Goodwin, G Caleb Alexander PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 73-73, 2022 | | 2022 |
| Risk of hospitalization and death associated with Pimavanserin use in older adults with Parkinson's disease HB Mehta, YJ Hwang, H An, T Moore, GC Alexander PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 631-632, 2022 | | 2022 |
| Development and validation of elixhauser summary comorbidity score for use with ICD-10-cm coded data among older adults H Mehta, S Li, H An, J Goodwin, GC Alexander, J Segal PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 446-446, 2022 | | 2022 |
| Abstract P146: Comparative Effectiveness Of Direct Oral Anticoagulants Versus Warfarin Among Medicare Beneficiaries With Atrial Fibrillation S Ardeshirrouhanifard, H An, R Goyal, M Raji, C Alexander, H Mehta Circulation 143 (Suppl_1), AP146-AP146, 2021 | | 2021 |
| Abstract P148: Initiation And Switching Of Direct Oral Anticoagulants Among Medicare Beneficiaries With Cancer And Atrial Fibrillation S Ardeshirrouhanifard, H An, R Goyal, M Raji, C Alexander, H Mehta Circulation 143 (Suppl_1), AP148-AP148, 2021 | | 2021 |
| Comparative Effectiveness Of Direct Oral Anticoagulants Versus Warfarin Among Medicare Beneficiaries With Atrial Fibrillation S Ardeshirrouhanifard, H An, R Goyal, M Raji, C Alexander, H Mehta CIRCULATION 143, 2021 | | 2021 |
| Use of hydroxychloroquine, remdesivir, and dexamethasone among adults hospitalized with COVID-19 in the United States: Results from the National COVID Cohort Collaborative (N3C) HB Mehta, HJ An, KM Andersen, O Mansour, V Madhira, ES Rashidi, ... Pharmacoepidemiology and Drug Safety, 27-27, 2021 | | 2021 |
| Utilizing the National COVID Cohort Collaborative (N3C) to evaluate risk of serious outcomes with COVID-19 among chronically immunosuppressed persons KM Andersen, ES Rashidi, HJ An, HB Mehta, DK Ng, BT Garibaldi, ... Pharmacoepidemiology and Drug Safety, 24-24, 2021 | | 2021 |
